<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73-vaccines-08-00273">
 <label>73.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Erasmus</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Seymour</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Kaelber</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>D.Y.</given-names>
   </name>
   <name>
    <surname>Leal</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sherman</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Frolov</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Chiu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Weaver</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Nasar</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono-and multivalent, single-dose protection against lethal Alphavirus challenge</article-title>
  <source>J. Virol.</source>
  <year>2018</year>
  <volume>92</volume>
  <fpage>e01274-17</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01274-17</pub-id>
  <?supplied-pmid 29187545?>
  <pub-id pub-id-type="pmid">29187545</pub-id>
 </element-citation>
</ref>
